Wake Up Wall Street (SPY) (QQQ): Nuclear threat sees European markets collapse but US jobs outperform
Premium|You have reached your limit of 5 free articles for this month.
BLACK FRIDAY SALE! 60% OFF!
Grab this special offer, it's 7 months for FREE deal! And access ALL our articles and analysis.
Your coupon code
FXS75
Here is what you need to know on Friday, March 4:
The financial markets have now gotten over the shock of the initial Russia-Ukraine conflict and had until today begun to price in more risk back into portfolios. However, that has now taken a back seat as news of Russia shelling a nuclear power plant in Ukraine and a fire in the plant sent European markets into a tailspin. The strong jobs report should at least provide some succour to US equitie,s but their European counterparts remain mired. This naturally has sent the dollar on another charge and hits 1.0920 versus the euro. Safe haven buying continues with German bund yields collapsing again, but notably the US yield curve remains on track to turn negative and signal a recession by early 2023.
The dollar index is at 98.67 now on the strong jobs report, Gold is higher at $1,941, and Oil is higher again at $112.10.
European markets are lower: Eurostoxx, FTSE and DAx are all just over 3% lower.
US futures are also lower: S&P, Dow and Nasdaq are all -0.75%
Wall Street Top News (SPY) (QQQ)
US nonfarm payrolls 678k versus 423k expected.
Apple (AAPL) rumoured to have a folding phone in development-CNBC.
AirBnB (ABNB) suspends all activity in Belarus and Russia.
GAP up 6% after earnings.
ING down 7% on Russian loan exposure.
Stellantis (STLA): Deutsche maintains Buy rating.
Pfizer (PFE) Pfizer Canada recalls blood pressure drug.
Nokia (NOK) sings three-year deal for 4G and 5G across Indonesia.
Smith & Wesson (SWBI) down sharply on earnings.
CRH drops -8% on earnings.
European Banks UBS, BCS, ING Deutsche all down sharply.
Sweetgreen (SG) sets strong guidance, shares up 17%.
Tilray (TLRY) upgraded by Cannacord.
Splunk (SPLK) up on private equity stake.
Broadcom (AVGO) up on strong earnings.
Upgrades and Downgrades
Souce: Benzinga Pro
Economic releases
Here is what you need to know on Friday, March 4:
The financial markets have now gotten over the shock of the initial Russia-Ukraine conflict and had until today begun to price in more risk back into portfolios. However, that has now taken a back seat as news of Russia shelling a nuclear power plant in Ukraine and a fire in the plant sent European markets into a tailspin. The strong jobs report should at least provide some succour to US equitie,s but their European counterparts remain mired. This naturally has sent the dollar on another charge and hits 1.0920 versus the euro. Safe haven buying continues with German bund yields collapsing again, but notably the US yield curve remains on track to turn negative and signal a recession by early 2023.
The dollar index is at 98.67 now on the strong jobs report, Gold is higher at $1,941, and Oil is higher again at $112.10.
European markets are lower: Eurostoxx, FTSE and DAx are all just over 3% lower.
US futures are also lower: S&P, Dow and Nasdaq are all -0.75%
Wall Street Top News (SPY) (QQQ)
US nonfarm payrolls 678k versus 423k expected.
Apple (AAPL) rumoured to have a folding phone in development-CNBC.
AirBnB (ABNB) suspends all activity in Belarus and Russia.
GAP up 6% after earnings.
ING down 7% on Russian loan exposure.
Stellantis (STLA): Deutsche maintains Buy rating.
Pfizer (PFE) Pfizer Canada recalls blood pressure drug.
Nokia (NOK) sings three-year deal for 4G and 5G across Indonesia.
Smith & Wesson (SWBI) down sharply on earnings.
CRH drops -8% on earnings.
European Banks UBS, BCS, ING Deutsche all down sharply.
Sweetgreen (SG) sets strong guidance, shares up 17%.
Tilray (TLRY) upgraded by Cannacord.
Splunk (SPLK) up on private equity stake.
Broadcom (AVGO) up on strong earnings.
Upgrades and Downgrades
Souce: Benzinga Pro
Economic releases
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.